Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent

NCT01303692 · clinicaltrials.gov ↗

COMPLETED

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

GnRH Agonist Alone vs. GnRH Agonist Plus Anti-androgen Combination Treated Prostate Cancer Patients

Sponsor

AstraZeneca